Orchestra Bio

Everything Threat Times has reported about Orchestra Bio: 2 stories, newest first. Part of our AI coverage.

AI

OpenAI Acquires Orchestra Bio to Integrate AI Agents Into Rosalind Suite

Threat TimesOct 20, 2026

OpenAI has acquired Orchestra Bio, a startup specializing in AI agents for drug development, with plans to incorporate the technology into its Rosalind life sciences platform.

AI

OpenAI Acquires Orchestra Bio to Advance AI in Life Sciences R&D

Threat TimesOct 20, 2026

OpenAI announces the acquisition of Orchestra Bio, aiming to integrate AI capabilities into biopharma research and accelerate drug development processes.